These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11021110)

  • 1. [An efficacy study of lodoxamide treatment in allergic eye lesions].
    Giuri S; Munteanu GH
    Oftalmologia; 2000; 50(1):68-76. PubMed ID: 11021110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of efficacy and safety of sterile solution of lodoxamide in patients with ocular allergy].
    Nicoară S
    Oftalmologia; 2001; 52(2):81-4. PubMed ID: 11771108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
    Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK
    Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the efficacy and safety of lodoxamide in patients with allergic eye diseases].
    Dekaris I; Gabrić N; Lazić R; Bosnar D; Cima I; Stipić A
    Acta Med Croatica; 2002; 56(3):93-8. PubMed ID: 12630339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lodoxamide as adjuvant therapy in patients with dry eye.
    Petricek I; Pokupec R; Petricek G; Salopek-Rabatić J
    Coll Antropol; 2001; 25 Suppl():149-52. PubMed ID: 11817007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alomide eyedrops in the treatment of allergic conjunctivitis and keratoconjunctivitis].
    Maĭchuk IuF; Khaitova KN; Grishakova MB
    Vestn Oftalmol; 1998; 114(4):43-4. PubMed ID: 9771090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging drugs for ocular allergy.
    Leonardi A
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):505-20. PubMed ID: 16083326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of lodoxamide in vernal keratoconjunctivitis.
    Das D; Khan M; Gul A; Alam R
    J Pak Med Assoc; 2011 Mar; 61(3):239-41. PubMed ID: 21465936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of lodoxamide eye drops on tear fluid cytology of patients with vernal conjunctivitis.
    Oguz H; Bitiren M; Aslan OS; Ozardali I
    Acta Med Okayama; 1999 Jun; 53(3):123-6. PubMed ID: 10410789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lodoxamide on tear leukotriene levels in giant papillary conjunctivitis associated with ocular prosthesis.
    Akman A; Irkeç M; Orhan M; Erdener U
    Ocul Immunol Inflamm; 1998 Sep; 6(3):179-84. PubMed ID: 9785608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM; Tekelioglu Y; Turk A; Akyol N
    Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
    Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS
    Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.
    Denis D; Bloch-Michel E; Verin P; Sebastiani A; Tazartes M; Helleboid L; Di Giovanni A; Lecorvec M
    Br J Ophthalmol; 1998 Oct; 82(10):1135-8. PubMed ID: 9924299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
    Greiner JV; Udell IJ
    Clin Ther; 2005 May; 27(5):568-77. PubMed ID: 15978305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis.
    Avunduk AM; Avunduk MC; Kapicioglu Z; Akyol N; Tavli L
    Ophthalmology; 2000 Jul; 107(7):1333-7. PubMed ID: 10890862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Corneal ulcerative lesions in type-I immediate hypersensitivity].
    Giuri S
    Oftalmologia; 1998; 44(3):20-6. PubMed ID: 10418608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lodoxamide for vernal keratoconjunctivitis.
    Med Lett Drugs Ther; 1994 Mar; 36(918):26. PubMed ID: 8121328
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population.
    Abelson MB; Ferzola NJ; McWhirter CL; Crampton HJ
    Pediatr Allergy Immunol; 2004 Dec; 15(6):551-7. PubMed ID: 15610370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical picture, diagnosis and therapy of allergic eye diseases].
    Groblewska A
    Pol Merkur Lekarski; 2003 Jun; 14(84):719-22. PubMed ID: 14524317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New aspects in drug therapy of ocular allergies].
    Maĭchuk IuF
    Vestn Oftalmol; 2000; 116(5):10-4. PubMed ID: 11221368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.